Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of British Columbia

$29,000.00

Surface Processing of Orthopaedic Implants for Controlled Drug Delivery and Enhanced Bone Integration

EF 2012-13

Résumé
The application of artificial joints such as total hip implants has greatly improved the quality of life of many people suffering from osteoarthritis and osteoporosis. With an aging population the demands for such devices will constantly rise. Although fairly reliable, current total hip arthroplasty is facing two critical and surface-related challenges that impair its longevity: the peri-implant infection, and the emerging issue of early implant failure due to inadequate bone growth and adverse tissue responses. Solutions to prevent or treat implant related infections are further complicated by the concern over the development of antibiotic resistance. To solve the problems of current orthopaedic implants, this proposal will follow two parallel, but closely related research strategies. Firstly, we will investigate the fundamental mechanisms for the early failure of total hip implants. We will analyze wear mechanisms of the retrieved implants, and the corrosion and wear products to identify sources of adverse tissue reactions. The surface topography and chemistry of the failed implants will also be analyzed for causes of inadequate bone growth. Secondly, lessons from the retrieved study will then be applied to improving implant longevity through innovative surface design and processing. The idea is to develop three dimensional composite nanostructures on the implant surface, from nanometer to micrometer scale, that could facilitate local drug loading with controlled release profile and at the same time enhance both growth. Various surface processing techniques such as anodizing and electrochemical deposition will be explored to achieve the designed surface structures, mainly out of bioactive ceramics such as titania and hydroxyapatite. Field-assisted loading and peptide-mediated mineralization techniques will be applied to load non-traditional antimicrobial agents such as antimicrobial peptides into the surface nanostructures. By the end of this project, we expect to develop a complete package of surface processing techniques and local drug delivery systems that could be used to significantly increase the clinical performance of current orthopaedic implants.
Programme
Discovery Grants Program - Individual
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
249524-2012
Name nom
Wang, Rizhi
Department département
Materials Engineering
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
29000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1208
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Materials sciences
Area of application fr
Sciences des matériaux
Research subject code
2006
Research subject group en
Materials science and technology
Research subject group fr
Science et technologie des matériaux
Research subject en
Biomaterials
Research subject fr
Biomatériaux
Partie
1
Nb partie
5
Application title
Surface Processing of Orthopaedic Implants for Controlled Drug Delivery and Enhanced Bone Integration
Keyword
NSERC
Application summary
The application of artificial joints such as total hip implants has greatly improved the quality of life of many people suffering from osteoarthritis and osteoporosis. With an aging population the demands for such devices will constantly rise. Although fairly reliable, current total hip arthroplasty is facing two critical and surface-related challenges that impair its longevity: the peri-implant infection, and the emerging issue of early implant failure due to inadequate bone growth and adverse tissue responses. Solutions to prevent or treat implant related infections are further complicated by the concern over the development of antibiotic resistance. To solve the problems of current orthopaedic implants, this proposal will follow two parallel, but closely related research strategies. Firstly, we will investigate the fundamental mechanisms for the early failure of total hip implants. We will analyze wear mechanisms of the retrieved implants, and the corrosion and wear products to identify sources of adverse tissue reactions. The surface topography and chemistry of the failed implants will also be analyzed for causes of inadequate bone growth. Secondly, lessons from the retrieved study will then be applied to improving implant longevity through innovative surface design and processing. The idea is to develop three dimensional composite nanostructures on the implant surface, from nanometer to micrometer scale, that could facilitate local drug loading with controlled release profile and at the same time enhance both growth. Various surface processing techniques such as anodizing and electrochemical deposition will be explored to achieve the designed surface structures, mainly out of bioactive ceramics such as titania and hydroxyapatite. Field-assisted loading and peptide-mediated mineralization techniques will be applied to load non-traditional antimicrobial agents such as antimicrobial peptides into the surface nanostructures. By the end of this project, we expect to develop a complete package of surface processing techniques and local drug delivery systems that could be used to significantly increase the clinical performance of current orthopaedic implants.